1-3 of 3
Antonio Ledda, M.D.
Close
Sort by
Journal Articles

A Phase III Study of Double Autotransplantation Incorporating Bortezomib-Thalidomide-Dexamethasone (VTD) or Thalidomide-Dexamethasone (TD) for Multiple Myeloma: Superior Clinical Outcomes with VTD Compared to TD.

Michele Cavo, M.D., Paola Tacchetti, M.D., Francesca Patriarca, M.D., Maria Teresa Petrucci, M.D., Lucia Pantani, M.D., Monica Galli, M.D., Francesco Di Raimondo, M.D., Claudia Crippa, M.D., Sara Bringhen, M.D., Massimo Offidani, M.D., Franco Narni, M.D., Vittorio Montefusco, M.D., Elena Zamagni, M.D., Tonino Spadano, M.D., Norbert Pescosta, M.D., Luca Baldini, M.D., Claudia Cellini, M.D., Tommaso Caravita, M.D., Antonio Ledda, M.D., Antonietta Falcone, M.D., Patrizia Tosi, M.D., Chiara Nozzoli, M.D., Renato Zambello, M.D., Luciano Masini, M.D., Paola Agostini, M.D., Mauro Fiacchini, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2009) 114 (22): 351.
https://doi.org/10.1182/blood.V114.22.351.351
Published: 2009
Journal Articles

Incorporation of Thalidomide-Dexamethasone (Thal-Dex) into up-Front Double Autologous Stem-Cell Transplantation (ASCT) for multiple Myeloma: Final analysis of phase II “Bologna 2002” Study.

Elena Zamagni, M.D., Nicoletta Testoni, B.S., Carolina Terragna, B.S., Paola Tacchetti, M.D., Chiara Nicci, B.S., Patrizia Tosi, M.D., Mauro Fiacchini, M.D., Francesca Patriarca, M.D., Francesco Di Raimondo, M.D., Lucio Catalano, M.D., Francesco Casulli, M.D., Silvestro Volpe, M.D., Luciano Masini, M.D., Antonio Ledda, M.D., Annamaria Brioli, M.D., Delia Cangini, M.D., Alessandro Gozzetti, M.D., Catello Califano, M.D., Claudia Cellini, M.D., Affra Carubelli, M.D., Alessandro Petrucci, M.D., Giuliana Leopardi, M.D., Lucia Pantani, M.D., Michela Ceccolini, M.D., Massimo Offidani, M.D., Giulia Perrone, M.D., Michele Baccarani, M.D., Michele Cavo, M.D.
Journal: Blood
Blood (2009) 114 (22): 349.
https://doi.org/10.1182/blood.V114.22.349.349
Published: 2009
Journal Articles

Superior Complete Response Rate and Progression-Free Survival after Autologous Transplantation with up-Front Velcade-Thalidomide- Dexamethasone Compared with Thalidomide-Dexamethasone in Newly Diagnosed Multiple Myeloma

Michele Cavo, M.D., Paola Tacchetti, M.D., Francesca Patriarca, M.D., Maria Teresa Petrucci, M.D., Lucia Pantani, M.D., Michela Ceccolini, M.D., Monica Galli, M.D., Francesco Di Raimondo, M.D., Claudia Crippa, M.D., Elena Zamagni, M.D., Patrizia Tosi, M.D., Franco Narni, M.D., Sara Bringhen, M.D., Vittorio Montefusco, M.D., Massimo Offidani, M.D., Silvia Buttignol, M.D., Anna Levi, M.D., Ausilia Gorgone, M.D., Annamaria Brioli, M.D., Maria Caterina Pallotti, M.D., Tonino Spadano, M.D., Norbert Pescosta, M.D., Luca Baldini, M.D., Antonio Ledda, M.D., Tommaso Caravita, M.D., Antonietta Falcone, M.D., Alfonso Zaccaria, M.D., Giulia Perrone, M.D., Alessandro Petrucci, M.D., Antonio Palumbo, M.D., Mario Boccadoro, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2008) 112 (11): 158.
https://doi.org/10.1182/blood.V112.11.158.158
Published: 2008